SHAREHOLDERS’ EQUITY (Tables)

12 Months Ended

Dec. 31, 2020


ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)	2020		2019		2018
Beginning balance	$	61	$	(39)	$	(102)
Other comprehensive income (loss) (OCI) before reclassifications – net of deferred taxes of $10, $32 and $41(a)	55		141		87
Reclassifications from OCI – net of deferred taxes of $(14), $(11) and $(6)	(56)		(42)		(23)
Other comprehensive income (loss)	(1)		100		64
Less OCI attributable to noncontrolling interests	—		—		—
Investment securities ending balance	$	60	$	61	$	(39)

Beginning balance	$	(4,818)	$	(6,134)	$	(4,661)
OCI before reclassifications – net of deferred taxes of $(25), $(98) and $29	(255)		41		(2,076)
Reclassifications from OCI – net of deferred taxes of $0, $(9) and $89(b)(c)	691		1,234		412
Other comprehensive income (loss)	435		1,275		(1,664)
Less OCI attributable to noncontrolling interests	2		(40)		(192)
Currency translation adjustments ending balance	$	(4,386)	$	(4,818)	$	(6,134)

Beginning balance	$	49	$	13	$	62
OCI before reclassifications – net of deferred taxes of $11, $6 and $(26)	(94)		(21)		(149)
Reclassifications from OCI – net of deferred taxes of $(11), $2 and $4(b)	17		58		98
Other comprehensive income (loss)	(77)		37		(51)
Less OCI attributable to noncontrolling interests	—		2		(2)
Cash flow hedges ending balance	$	(28)	$	49	$	13

Beginning balance	$	(7,024)	$	(8,254)	$	(9,702)
OCI before reclassifications – net of deferred taxes of $(283), $(418) and $115	(1,256)		(2,097)		71
Reclassifications from OCI – net of deferred taxes of $805, $915 and $2,610 (b)(c)	2,888		3,325		1,345
Other comprehensive income (loss)	1,632		1,228		1,416
Less OCI attributable to noncontrolling interests	4		(2)		(32)
Benefit plans ending balance	$	(5,395)	$	(7,024)	$	(8,254)

Accumulated other comprehensive income (loss) at December 31	$	(9,749)	$	(11,732)	$	(14,414)

(a) Included adjustments of $(1,979) million, $(2,693) million and $1,825 million in 2020, 2019 and 2018, respectively, related to insurance liabilities and annuity benefits in our run-off insurance operations to reflect the effects that would have been recognized had the related unrealized investment security gains been realized. See Note 12 for further information.

(b) The total reclassification from AOCI included $836 million, including currency translation of $688 million, net of taxes, in 2020, related to the sale of our BioPharma business within our Healthcare segment.

(c) Currency translation and benefit plan gains and losses included $1,343 million, including currency translation of $1,066 million, net of taxes, in 2019 earnings (loss) from discontinued operations related to deconsolidation of Baker Hughes.